Search

everythinglearnresearchcommunity

for

Search:↓

Drospirenone is a unique progestin with anti-water retention and potential blood pressure benefits, used in birth control and hormone therapy.

The conclusion is that managing androgen excess requires long-term treatment, including hormonal contraceptives and androgen blockers, with follow-up after six months.

Androgenetic alopecia involves genetics, hormones, and can be treated with medications or surgery.

Hormones, especially androgens, play a key role in acne, which can be a symptom of systemic diseases like PCOS and may require targeted treatment.

Some treatments, like corticosteroids and sensitizing agents, can help with alopecia areata, but more high-quality research is needed.

Oral finasteride works better than topical minoxidil for hair growth, both are safe.

Some parents have a mild form of congenital adrenal hyperplasia without symptoms, and they usually don't need treatment.

Botulinum toxins effectively treat excessive sweating and may help with other skin conditions, but more research is needed.

Research on epidermal stem cells has advanced significantly, showing promise for improved clinical therapies.

Cancer treatments can cause various eye problems, so eye doctors should know how to diagnose and treat these early.

Allergic cats with yeast overgrowth improved with antifungal treatment.

Small molecule drugs show promise for advancing regenerative medicine but still face development challenges.

Female pattern hair loss diagnosed by scalp appearance, treated with combined therapies and targeted approaches.

Hair problems are common and distressing for women, but increasing knowledge of treatments offers hope.

Gene therapy shows promise for healing chronic wounds but needs more research to overcome challenges.

New treatments targeting skin stem cells show promise for skin repair, anti-aging, and cancer therapy.

ALA-PDT is effective and safe for chronic X-ray dermatitis, providing complete or partial remission.

Women with scarring alopecia have a lower quality of life and more anxiety and depression than those with non-scarring alopecia.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

Oral ciclosporin A and topical treatments both reduce hair loss and scaling in dogs with sebaceous adenitis, but using both together is most effective.

Repigmentation in vitiligo may come from melanocyte stem cells in the skin.

The document concludes that health care providers should offer culturally competent care and more research is needed to improve health outcomes for transgender individuals.

Women have a higher risk of blood clots from hormonal factors and need careful treatment, especially during pregnancy.

DHEA may help with sexual function when used intravaginally by menopausal women but is similar to hormone therapy in other aspects and might cause more side effects like acne and hair loss.

Herbal treatments may help manage seborrhea dermatitis effectively.

The review highlights the need for more research on transgender dermatology, the role of dermatologists in gender affirmation, and the effects of hormone therapy on skin and hair.

Hair diseases can have psychological effects and should be treated with a combination of psychosomatic care, therapy, and medication.

Women with polycystic ovarian syndrome are more likely to have cervical insufficiency, especially South Asian and Black women.

Skin problems in older people can indicate hormonal diseases, nutritional deficiencies, or conditions like diabetes, menopause, and HIV.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.